Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Other Accumulated Expenses (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Other Accumulated Expenses for 16 consecutive years, with $97.3 million as the latest value for Q1 2026.

  • Quarterly Other Accumulated Expenses fell 7.01% to $97.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $97.3 million through Jan 2026, down 7.01% year-over-year, with the annual reading at $97.3 million for FY2026, 7.01% down from the prior year.
  • Other Accumulated Expenses for Q1 2026 was $97.3 million at Usana Health Sciences, down from $102.4 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $147.3 million in Q1 2022, with the low at $97.2 million in Q2 2024.
  • Average Other Accumulated Expenses over 5 years is $112.2 million, with a median of $104.6 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses fell 19.95% in 2022, then increased 6.66% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $132.8 million in 2022, then dropped by 18.67% to $108.0 million in 2023, then fell by 3.1% to $104.6 million in 2024, then fell by 2.1% to $102.4 million in 2025, then fell by 5.02% to $97.3 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $97.3 million, $102.4 million, and $103.7 million for Q1 2026, Q3 2025, and Q2 2025 respectively.